Novartis Says Early Addition of Cholesterol Drug Shows Positive Results in Trial : vimarsana.com

Novartis Says Early Addition of Cholesterol Drug Shows Positive Results in Trial

By Adria Calatayud


Novartis said new data from a late-stage clinical trial showed that early addition of its Leqvio drug reduced cholesterol in patients with atherosclerotic cardiovascular...

Related Keywords

Switzerland , Swiss , Adria Calatayud , Novartis , Dow Jones ,

© 2024 Vimarsana